China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Metrics to compare | SXTC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSXTCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −54.1x | −7.5x | −0.6x | |
PEG Ratio | −0.59 | −0.01 | 0.00 | |
Price/Book | 11.6x | 0.4x | 2.6x | |
Price / LTM Sales | 102.6x | 1.5x | 3.2x | |
Upside (Analyst Target) | - | 2.1% | 41.8% | |
Fair Value Upside | Unlock | 5.8% | 5.1% | Unlock |